Tyriaq Establishes Strategic Manufacturing Partnership with Hi Pharm

Tyriaq Establishes Strategic Manufacturing Partnership with Hi Pharm

Tyriaq has entered into a strategic manufacturing partnership with Hi Pharm to produce selected hormone-based therapies within Hi Pharm’s specialized and highly controlled manufacturing facilities. This collaboration represents a significant step in expanding Tyriaq’s capabilities in areas requiring dedicated expertise and stringent production standards.

Hi Pharm’s advanced infrastructure and long-standing experience in hormonal therapy manufacturing enable Tyriaq to strengthen its development pipeline in women’s health and other endocrine-related therapeutic areas. Hi Pharm’s specialized capabilities provide Tyriaq with essential technical depth and scalability for products requiring high-precision manufacturing environments.

This partnership reinforces Tyriaq’s commitment to developing value-enhanced therapies across diverse therapeutic areas and to working with best-in-class regional partners.